SCHEMBL3682591

SCHEMBL3682591

COCNC(=O)c1ccc(Cl)cc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.51
CNR2 P34972 1/20 0.47
POLB P06746 2/20 0.47
THRB P10828 1/20 0.47
RECQL P46063 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
CYP11B2 P19099 1/20 0.46
SLC6A4 P31645 1/20 0.45
KDM4E B2RXH2 1/20 0.45
MAPT P10636 1/20 0.45
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
PYGL P06737 1/20 0.44
ALDH1A1 P00352 2/20 0.43
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
GAA P10253 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20447645 0.80 KDM4E (0.68) LMNACNR2L3MBTL1CYP11B2KDM4E
SCHEMBL28460519 0.80 POLB (0.72) LMNACNR2POLBTHRBRECQL
SCHEMBL11909258 0.79 ESRRG (0.36) LMNACNR2KMT2AHPGD
SCHEMBL19835910 0.78 CDK1 (0.54) LMNACNR2POLBTHRBRECQL
SCHEMBL14903858 0.77 GAA (0.56) LMNACYP11B2KDM4EMAPTALDH1A1
SCHEMBL1350185 0.77 ABL1 (0.64) POLBL3MBTL1CYP11B2SLC6A4KDM4E
SCHEMBL25762484 0.76 TRPA1 (0.56) LMNACNR2CYP11B2KDM4EALDH1A1
SCHEMBL9264240 0.75 ABL1 (0.45) LMNACYP11B2SLC6A4KDM4EMAPT
SCHEMBL24386436 0.75 TDP1 (0.49) LMNACNR2POLBTHRBRECQL
SCHEMBL4105512 0.74 MEN1 (0.45) LMNACNR2PYGLRAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7655641-B2 Sulfonamide derivatives as PPAR modulators ELI LILLY AND COMPANY (US) 2010-02-02 US disclosed
US-20060217433-A1 Sulfonamide derivatives as ppar modulators ELI LILLY AND COMPANY (US) 2006-09-28 US disclosed
EP-1597248-A2 SULFONAMIDE DERIVATIVES AS PPAR MODULATORS ELI LILLY AND COMPANY (US) 2005-11-23 EP disclosed
WO-2004073606-A2 SULFONAMIDE DERIVATIVES AS PPAR MODULATORS ELI LILLY AND COMPANY (US) 2004-09-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060217433-A1 Sulfonamide derivatives as ppar modulators PPARD, PPARA, PPARG LMNA 3056/4885CNR2 105/4885POLB 2436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.